Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 73

    1.

    Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine.

    Janka HU.

    Diabetes Obes Metab. 2008 Jul;10 Suppl 2:35-41. Review.PMID: 18577155 [PubMed - indexed for MEDLINE]Related articles

    3.

    Economic evaluation of the treatment of type 2 diabetes with insulin glargine based on the LAPTOP trial.

    Janka HU, Högy B.

    Eur J Health Econ. 2008 May;9(2):165-70. Epub 2007 May 26.PMID: 17530309 [PubMed - indexed for MEDLINE]Related articles

    4.

    Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.

    Janka HU, Plewe G, Busch K.

    J Am Geriatr Soc. 2007 Feb;55(2):182-8.PMID: 17302653 [PubMed - indexed for MEDLINE]Related articles

    5.

    C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.

    Linnemann B, Voigt W, Nobel W, Janka HU.

    Exp Clin Endocrinol Diabetes. 2006 Mar;114(3):127-34.PMID: 16636979 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.

    Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H.

    Diabetes Care. 2005 Feb;28(2):254-9.PMID: 15677775 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Detecting type 2 diabetes by a single post-challenge blood sample.

    Haeckel R, Wosniok W, Raber R, Janka HU.

    Clin Chem Lab Med. 2003 Sep;41(9):1251-8.PMID: 14598878 [PubMed - indexed for MEDLINE]Related articles

    8.

    [How to defuse the diabetes mellitus time bomb: identify early signs and vascular injuries, minimize risk factors]

    Janka HU.

    MMW Fortschr Med. 2003 May 22;145(21):29-30. German. No abstract available. PMID: 12845863 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study.

    Linnemann B, Janka HU.

    Exp Clin Endocrinol Diabetes. 2003 Jun;111(4):215-22.PMID: 12845560 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Differential pain and swelling of the lower leg diagnosis with color-coded duplex ultrasound]

    Nobel W, Janka HU.

    Praxis (Bern 1994). 2003 Jun 11;92(24):1133-5. German. No abstract available. PMID: 12841104 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.

    Holzgreve H, Nakov R, Beck K, Janka HU.

    Am J Hypertens. 2003 May;16(5 Pt 1):381-6.PMID: 12745200 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparability of blood glucose concentrations measured in different sample systems for detecting glucose intolerance.

    Haeckel R, Brinck U, Colic D, Janka HU, Püntmann I, Schneider J, Viebrock C.

    Clin Chem. 2002 Jun;48(6 Pt 1):936-9. No abstract available. PMID: 12029012 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Epidemiology of diabetes mellitus: prevalence, incidence, pathogenesis, and prognosis]

    Janka HU, Michaelis D.

    Z Arztl Fortbild Qualitatssich. 2002 Mar;96(3):159-65. German. PMID: 12017759 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Glitazones. Profile of a new class of substances]

    Janka HU.

    Internist (Berl). 2001 Apr;42(4):587-96. Review. German. No abstract available. PMID: 11326741 [PubMed - indexed for MEDLINE]Related articles

    15.

    [++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340]

    Janka HU.

    Internist (Berl). 2000 Jul;41(7):688-9. Review. German. No abstract available. PMID: 10929259 [PubMed - indexed for MEDLINE]Related articles

    16.

    [New diabetes criteria: impact on prevalence of a high risk cardiovascular population in Germany]

    Janka HU.

    Dtsch Med Wochenschr. 1999 Sep 17;124(37):1055-6. German. No abstract available. PMID: 10520304 [PubMed - indexed for MEDLINE]Related articles

    17.

    Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study.

    Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert ED, Janka HU, Kastendiek C, Sorger M, Louwen F, Ziegler AG.

    Diabetologia. 1999 Jun;42(6):671-7.PMID: 10382586 [PubMed - indexed for MEDLINE]Related articles

    18.

    Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs.

    Warram JH, Kopczynski J, Janka HU, Krolewski AS.

    Endocrinol Metab Clin North Am. 1997 Mar;26(1):165-88. Review.PMID: 9074858 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Diabetic foot syndrome--etiology and differential therapy]

    Janka HU.

    Dtsch Med Wochenschr. 1997 Feb 21;122(8):244; author reply 244-5. German. No abstract available. PMID: 9081816 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Epidemiology of the metabolic syndrome]

    Janka HU.

    Internist (Berl). 1996 Jul;37(7):681-6. Review. German. No abstract available. PMID: 8766261 [PubMed - indexed for MEDLINE]Related articles

    21.

    Increased cardiovascular morbidity and mortality in diabetes mellitus: identification of the high risk patient.

    Janka HU.

    Diabetes Res Clin Pract. 1996 Feb;30 Suppl:85-8. Review.PMID: 8964198 [PubMed - indexed for MEDLINE]Related articles

    22.

    No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.

    Roll U, Nuber A, Schröder A, Gerlach E, Janka HU, Ziegler AG.

    Diabetes Care. 1995 Feb;18(2):210-5.PMID: 7729299 [PubMed - indexed for MEDLINE]Related articles

    23.

    [Insulin resistance and cardiovascular complications]

    Janka HU.

    Wien Klin Wochenschr. 1994;106(24):758-62. Review. German. PMID: 7846894 [PubMed - indexed for MEDLINE]Related articles

    24.

    [Hypertension and diabetes mellitus]

    Janka HU.

    Z Gesamte Inn Med. 1993 Mar;48(3):157-61. Review. German. PMID: 8475640 [PubMed - indexed for MEDLINE]Related articles

    25.

    [Metabolic syndrome and type-II diabetes. Relations to macroangiopathy]

    Janka HU.

    Fortschr Med. 1992 Dec 10;110(34):637-41. Review. German. PMID: 1483615 [PubMed - indexed for MEDLINE]Related articles

    26.

    Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus.

    Baumgartl HJ, Standl E, Schmidt-Gayk H, Kolb HJ, Janka HU, Ziegler AG.

    Diabetes Res. 1991 Mar;16(3):145-8.PMID: 1666347 [PubMed - indexed for MEDLINE]Related articles

    27.

    [Antihypertensive therapy with co-dergocrine mesilate/nifedipine in comparison with nifedipine in type II diabetes]

    Janka HU, Mehnert H.

    Arzneimittelforschung. 1990 Sep;40(9):980-3. German. PMID: 2080948 [PubMed - indexed for MEDLINE]Related articles

    28.

    Metabolic effects of ramipril treatment in hypertensive subjects with non-insulin-dependent diabetes mellitus.

    Janka HU, Nuber A, Mehnert H.

    Arzneimittelforschung. 1990 Apr;40(4):432-5.PMID: 2141472 [PubMed - indexed for MEDLINE]Related articles

    29.

    Alterations in Na+, K+ and Ca2+ transport in erythrocytes of patients with carcinomas of the head and neck: possible role of mild anaemia and cell age.

    Engelmann B, Grevers G, Janka HU, Duhm J.

    Clin Sci (Lond). 1990 Mar;78(3):315-20.PMID: 2156652 [PubMed - indexed for MEDLINE]Related articles

    30.

    [Risk profile and macroangiopathy in type II diabetics in medical practice]

    Stiegler H, Standl E, Standl R, Rebell B, Ziegler A, Janka HU, Schulz K, Roth R, Lehmacher W.

    Vasa. 1990;19(2):119-28. German. PMID: 2371785 [PubMed - indexed for MEDLINE]Related articles

    31.

    Epidemiology and risk factors of macrovascular disease in diabetes mellitus.

    Janka HU.

    Horm Metab Res Suppl. 1990;22:8-11. Review.PMID: 2202634 [PubMed - indexed for MEDLINE]Related articles

    32.

    Hypertension and micro-albuminuria in diabetic patients taking indapamide.

    Janka HU, Weitz T, Blümner E, van Michel A, Mehnert H.

    J Hypertens Suppl. 1989 Dec;7(6):S316-7.PMID: 2632730 [PubMed - indexed for MEDLINE]Related articles

    33.

    [The effect of the beta 1 selective beta blocker, betaxolol, on metabolism in type II diabetics]

    Janka HU, Ziegler AG, Larrat V, Mehnert H.

    Arzneimittelforschung. 1989 May;39(5):615-7. German. PMID: 2569309 [PubMed - indexed for MEDLINE]Related articles

    34.

    Risk factors for progression of background retinopathy in long-standing IDDM.

    Janka HU, Warram JH, Rand LI, Krolewski AS.

    Diabetes. 1989 Apr;38(4):460-4.PMID: 2647552 [PubMed - indexed for MEDLINE]Related articles

    35.

    Impact of blood pressure on diabetic retinopathy.

    Janka HU, Ziegler AG, Valsania P, Warram JH, Krolewski AS.

    Diabete Metab. 1989;15(5 Pt 2):333-7. Review.PMID: 2693152 [PubMed - indexed for MEDLINE]Related articles

    36.

    Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study.

    Park JW, Ziegler AG, Janka HU, Doering W, Mehnert H.

    Klin Wochenschr. 1988 Sep 1;66(17):773-8.PMID: 3184761 [PubMed - indexed for MEDLINE]Related articles

    37.

    Influence of ketanserin on glucose and lipid metabolism in diabetic patients with hypertension.

    Janka HU, Mehnert H, Fisher R, Seiler KU.

    Drugs. 1988;36 Suppl 1:123-5. No abstract available. PMID: 3240726 [PubMed - indexed for MEDLINE]Related articles

    38.

    [Proteinuria in diabetes mellitus--a prognostic indicator even in type II?]

    Janka HU.

    Dtsch Med Wochenschr. 1987 Sep 18;112(38):1443-4. German. No abstract available. PMID: 3622291 [PubMed - indexed for MEDLINE]Related articles

    39.

    Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.

    Janka HU, Ziegler AG, Standl E, Mehnert H.

    Diabete Metab. 1987 Jul;13(3 Pt 2):359-64.PMID: 3308565 [PubMed - indexed for MEDLINE]Related articles

    40.

    Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.

    Janka HU, Standl E.

    Diabete Metab. 1987 Jul;13(3 Pt 2):279-83. Review. No abstract available. PMID: 3308556 [PubMed - indexed for MEDLINE]Related articles

    41.

    [Transient ischemic attacks in primary hyperparathyroidism. Prevention with calcium antagonists]

    Ziegler AG, Janka HU, Mehnert H.

    Dtsch Med Wochenschr. 1987 Feb 27;112(9):345-6. German. PMID: 3816609 [PubMed - indexed for MEDLINE]Related articles

    42.

    Influence of bisoprolol on blood glucose, glucosuria, and haemoglobin A1 in noninsulin-dependent diabetics.

    Janka HU, Ziegler AG, Disselhoff G, Mehnert H.

    J Cardiovasc Pharmacol. 1986;8 Suppl 11:S96-9.PMID: 2439808 [PubMed - indexed for MEDLINE]Related articles

    43.

    Systolic blood pressure as a predictor for cardiovascular disease in diabetes. A 5-year longitudinal study.

    Janka HU, Dirschedl P.

    Hypertension. 1985 Nov-Dec;7(6 Pt 2):II90-4.PMID: 4077243 [PubMed - indexed for MEDLINE]Related articles

    44.

    High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes.

    Standl E, Janka HU.

    Horm Metab Res Suppl. 1985;15:46-51.PMID: 3908281 [PubMed - indexed for MEDLINE]Related articles

    45.

    Five-year incidence of major macrovascular complications in diabetes mellitus.

    Janka HU.

    Horm Metab Res Suppl. 1985;15:15-9.PMID: 3865879 [PubMed - indexed for MEDLINE]Related articles

    46.

    Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication).

    Janka HU.

    Horm Metab Res Suppl. 1985;15:120-2. No abstract available. PMID: 2934311 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Heart and circulatory disorders in diabetics. Prognostic indices and preventive measures]

    Janka HU.

    Lebensversicher Med. 1983 Nov 15;35(9):202-6. German. No abstract available. PMID: 6140609 [PubMed - indexed for MEDLINE]Related articles

    48.

    Platelet enzyme activities in diabetes mellitus in relation to endothelial damage.

    Janka HU, Standl E, Schramm W, Mehnert H.

    Diabetes. 1983 May;32 Suppl 2:47-51.PMID: 6086025 [PubMed - indexed for MEDLINE]Related articles

    49.

    [Macroangiopathy in diabetes mellitus]

    Janka HU.

    Med Welt. 1983 Feb 4;34(5):153-7. German. No abstract available. PMID: 6843340 [PubMed - indexed for MEDLINE]Related articles

    50.

    No rationale for antiplatelet drug treatment in diabetic ketoacidosis.

    Janka HU, Mehnert H.

    Diabetologia. 1982 Sep;23(3):286. No abstract available. PMID: 6813170 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...